Morphic Holding, Inc. | Business Contracts

Registration Rights Agreement, dated February 13, 2023, by and among Morphic Holding, Inc. and the investors listed on the signature pages thereto (Filed With SEC on February 13, 2023)

Amended and Restated 2019 Equity Incentive Plan (Filed With SEC on August 3, 2022)

Amendment No (Filed With SEC on November 4, 2021)

Amendment No. 2 to Research Collaboration and Option Agreement, dated as of June 18, 2021, by and between the Registrant and Janssen Pharmaceuticals, Inc (Filed With SEC on August 4, 2021)

Exclusive License Agreement, dated October 7, 2015, by and between Children's Medical Center Corporation and the Registrant, as amended (Filed With SEC on June 14, 2019)

Lease, dated August 5, 2015, by and between the Registrant and AstraZeneca Pharmaceuticals Limited Partnership, as amended (Filed With SEC on June 14, 2019)

Securities Purchase Agreement, dated February 13, 2023, by and among Morphic Holding, Inc. and the investors listed on the signature pages thereto (Filed With SEC on February 13, 2023)

Form of Pre-Funded Warrant (Filed With SEC on February 13, 2023)

Form of Change in Control and Severance Agreement (Filed With SEC on February 24, 2022)

Change in Control and Severance Agreement dated February 20, 2020 by and between the Registrant and Peter Linde (Filed With SEC on April 29, 2021)

Offer Letter, dated February 20, 2020, by and between the Registrant and Peter Linde (Filed With SEC on April 29, 2021)

Underwriting Agreement dated March 2, 2021 (Filed With SEC on March 3, 2021)

Amendment No. 1 to the Research Collaboration and Option Agreement, dated December 30, 2020, by and among Janssen Pharmaceuticals, Inc. and the Registrant (Filed With SEC on March 1, 2021)

Description of Registrants Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 1, 2021)

Severance Agreement dated February 3, 2020 by and between Marc Schegerin and Morphic Holding, Inc (Filed With SEC on August 10, 2020)

Offer Letter, dated February 3, 2020, by and between Marc Schegerin, and Morphic Holding, Inc (Filed With SEC on August 10, 2020)

Offer Letter, dated June 10, 2019, by and between the Registrant and William DeVaul (Filed With SEC on February 27, 2020)

Consulting Agreement, dated December 5, 2019, by and between the Registrant and Timothy A. Springer, Ph.D (Filed With SEC on February 27, 2020)

Description of Registrants Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on February 27, 2020)

Collaboration and Option Agreement, dated October 16, 2018, by and between AbbVie Biotechnology Ltd and the Registrant (Filed With SEC on June 24, 2019)

Form Stock Restriction Agreement (Filed With SEC on June 14, 2019)

Change in Control and Severance Agreement, dated June 12, 2019 by and between the Company and Praveen P. Tipirneni, MD, to become effective on the date immediately prior to the... (Filed With SEC on June 14, 2019)

Investors' Rights Agreement, dated December 5, 2018, by and among the Registrant and certain of its stockholders (Filed With SEC on June 14, 2019)

Warrant by and between the Registrant and Silicon Valley Bank (Filed With SEC on June 14, 2019)

Form of Indemnity Agreement (Filed With SEC on June 14, 2019)

2018 Stock Incentive Plan, and forms of award agreements (Filed With SEC on June 14, 2019)

2019 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on June 14, 2019)

2019 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on June 14, 2019)

Offer Letter, dated June 10, 2019, by and between Morphic Therapeutic, Inc. and Praveen P. Tipirneni, MD., to become effective on the date immediately prior to the date the... (Filed With SEC on June 14, 2019)

Offer Letter, dated June 10, 2019, by and between Morphic Therapeutic, Inc. and Bruce N. Rogers, Ph.D., to become effective on the date immediately prior to the date the... (Filed With SEC on June 14, 2019)

Offer Letter, dated June 10, 2019, by and between Morphic Therapeutic, Inc. and Alexey A. Lugovskoy, Ph.D., to become effective on the date immediately prior to the date the... (Filed With SEC on June 14, 2019)

Consulting Agreement, dated June 1, 2015, by and between the Registrant and Timothy A. Springer, Ph.D (Filed With SEC on June 14, 2019)

Collaboration Agreement, dated June 10, 2015, by and between Morphic Rock Therapeutic, Inc. and Schrdinger, LLC, as amended (Filed With SEC on June 14, 2019)

Form of Underwriting Agreement (Filed With SEC on June 14, 2019)

Collaboration and Option Agreement, dated October 16, 2018, by and between AbbVie Biotechnology Ltd and the Registrant (Filed With SEC on June 14, 2019)

Research Collaboration and Option Agreement, dated February 15, 2019, by and among Janssen Pharmaceuticals, Inc. and the Registrant (Filed With SEC on June 14, 2019)

Change in Control and Severance Agreement, dated June 12, 2019 by and between the Company and Bruce N. Rogers, Ph.D., to become effective on the date immediately prior to the date... (Filed With SEC on June 14, 2019)

Change in Control and Severance Agreement, dated June 12, 2019 by and between the Company and Alexey A. Lugovskoy, Ph.D., to become effective on the date immediately prior to the... (Filed With SEC on June 14, 2019)

Form of Common Stock Certificate (Filed With SEC on June 14, 2019)

Collaboration and Option Agreement, dated October 16, 2018, by and between AbbVie Biotechnology Ltd and the Registrant (Filed With SEC on May 30, 2019)

Investors' Rights Agreement, dated December 5, 2018, by and among the Registrant and certain of its stockholders (Filed With SEC on May 30, 2019)

Lease, dated August 5, 2015, by and between the Registrant and AstraZeneca Pharmaceuticals Limited Partnership, as amended (Filed With SEC on May 30, 2019)

Exclusive License Agreement, dated October 7, 2015, by and between Children's Medical Center Corporation and the Registrant, as amended (Filed With SEC on May 30, 2019)

Collaboration Agreement, dated June 10, 2015, by and between Morphic Rock Therapeutic, Inc. and Schrdinger, LLC, as amended (Filed With SEC on May 30, 2019)

Consulting Agreement, dated June 1, 2015, by and between the Registrant and Timothy A. Springer, Ph.D (Filed With SEC on May 30, 2019)

2018 Stock Incentive Plan, and forms of award agreements (Filed With SEC on May 30, 2019)

Warrant by and between the Registrant and Silicon Valley Bank (Filed With SEC on May 30, 2019)

Research Collaboration and Option Agreement, dated February 15, 2019, by and among Janssen Pharmaceuticals, Inc. and the Registrant (Filed With SEC on May 30, 2019)

Morphic Holding, Inc. (48)